Report to the directors on the preparation of the unaudited statutory accounts of Celix Pharma Ltd for the year ended 31 March 2025.


In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Celix Pharma Ltd for the year ended 31 March 2025 which comprise of the Profit and Loss Account, the Statement of Comprehensive Income, the Balance Sheet, the Statement of Changes in Equity and the related notes from the companys accounting records and from information and explanations you have given us.


As a practising member firm of the Association of Chartered Certified Accountants, we are subject to its ethical and other professional requirements which are detailed at http://rulebook.accaglobal.com/.


This report is made solely to the Board of Directors of Celix Pharma Ltd, as a body, in accordance with the terms of our engagement letter dated 24 December 2025 Our work has been undertaken solely to prepare for your approval the accounts of Celix Pharma Ltd and state those matters that we have agreed to state to the Board of Directors of Celix Pharma Ltd, as a body, in this report in accordance with the requirements of the Association of Chartered Certified Accountants as detailed at http://www.accaglobal.com/factsheet163. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Celix Pharma Ltd and its Board of Directors as a body for our work or for this report.


It is your duty to ensure that Celix Pharma Ltd has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Celix Pharma Ltd. You consider that Celix Pharma Ltd is exempt from the statutory audit requirement for the year.


We have not been instructed to carry out an audit or a review of the accounts of Celix Pharma Ltd. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts
31 March 2025.

Celix Pharma Ltd is a private company, limited by shares, registered in England and Wales, registration number 12474195, registration address 12 Constance Street, E16 2DQ.

The presentation currency is £ sterling.